Your browser doesn't support javascript.
Factors associated with disease severity of COVID­19 in patients with type 2 diabetes mellitus.
Novida, Hermina; Soelistyo, Soebagijo Adi; Cahyani, Cupuwatie; Siagian, Nency; Hadi, Usman; Pranoto, Agung.
  • Novida H; Division of Endocrinology, Diabetes and Metabolism, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, East Java 60132, Indonesia.
  • Soelistyo SA; Division of Endocrinology, Diabetes and Metabolism, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, East Java 60132, Indonesia.
  • Cahyani C; Department of Internal Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, East Java 60132, Indonesia.
  • Siagian N; Department of Internal Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, East Java 60132, Indonesia.
  • Hadi U; Division of Tropical and Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, East Java 60132, Indonesia.
  • Pranoto A; Division of Endocrinology, Diabetes and Metabolism, Faculty of Medicine, Airlangga University, Dr Soetomo General Hospital, Surabaya, East Java 60132, Indonesia.
Biomed Rep ; 18(1): 8, 2023 Jan.
Article in English | MEDLINE | ID: covidwho-2163771
ABSTRACT
Diabetes mellitus causes a decline in immunological function, an increase in proinflammatory cytokines, and a prothrombotic state, thus providing risk factors for the severity of coronavirus disease 2019 (COVID-19) in patients with type 2 diabetes mellitus (T2DM). The aim of the present study was to analyze the risk factors associated with the severity of COVID-19 in patients with T2DM. A cross-sectional observational study was performed on 201 patients with T2DM from May 1 to August 31, 2020 and admitted to the isolation ward of Dr Soetomo General Hospital (Surabaya, Indonesia). The patients were divided into severe (108 cases; 53.7%) and non-severe (93 cases; 46.3%) groups, which were considered the dependent variables. Univariate and multivariate analysis was performed. The independent variables were age, sex, diabetes onset, chronic complications, presence of hypertension, randomized blood glucose, HbA1c, albumin, and neutrophil-lymphocyte ratio (NLR). A P-value <0.05 was considered to be statistically significant. The median age of the 201 subjects was 56 years, with 70.1% <60 years old, 52.7% male, 76.1% with diabetes onset <10 years, and 108 patients (53.7%) in severe condition. The results of the bivariate analysis revealed that diabetes onset >10 years (OR 2.5; P=0.011) was associated with severity of COVID-19 in patients with T2DM, however hypoalbumin (OR 1.93; P=0.054) was not associated with disease severity. Furthermore, multivariate analysis revealed that male sex (OR 2.07; P=0.042), age (≥60 years) (OR 2.92; P=0.008), HbA1c (≥8%) (OR 3.55; P=0.001), hypertension (OR 4.07; P=0.001), and an NLR ≥7.36 (OR 6.39; P=0.001) were associated with severe COVID-19. Collectively, it was revealed that increased NLR, hypertension, poor glycemic control, older age, and male sex were risk factors associated with the severity of COVID-19 among diabetic patients.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Biomed Rep Year: 2023 Document Type: Article Affiliation country: Br.2022.1590

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Biomed Rep Year: 2023 Document Type: Article Affiliation country: Br.2022.1590